26 news items
Page 2 of 2
98my24bev1 dm0i52m4ls9535bikc1g6bj5me28z4m
REGN
29 Apr 24
extensive data presentations at ARVO showcase the differentiated efficacy, safety and durability of EYLEA HD, and demonstrate our commitment to advancing
vlx7ni87oubdd4be4qqek6mbvi2h qwd2z
REGN
24 Apr 24
at the American Society of Clinical Oncology (ASCO) 2024 Annual Meeting, taking place from May 31 to June 5 in Chicago, IL. Notably, new safety and efficacy
d1i8i2yl931y5111sk pisrcn0o54xoc4lh
REGN
22 Apr 24
; safety issues resulting from the administration of Regeneron's Products and Regeneron's Product Candidates (such as DB-OTO) in patients, including
g2j8o5bd3y7nxd4vrk htkyv6vh
REGN
7 Apr 24
. Linvoseltamab is currently under clinical development, and its safety and efficacy have
lu6x65lwq6pup7vk1afz88oq6rzvni
REGN
25 Mar 24
with clinical efficacy or safety, trial design, labeling, or manufacturing.
Regeneron has been actively enrolling patients in multiple Phase
dx7lzzl69xus8k2ubvgty29sohplttqu598qwlve02ky4hz5ck0vj74tgo
REGN
25 Mar 24
not identify any approvability issues with the odronextamab clinical efficacy or safety, trial design, labeling or manufacturing